N/A
N=11,120
Project Resurgence Communication Trial
Communication Research
Bottom Line
View on ClinicalTrials.gov: NCT04418947 ↗Enrolled (actual)
11,120
Serious AEs
0.0%
Results posted
Oct 2021
Primary outcome: Primary: Percent of Participants With Visit or Procedure With Provider — 45; 64; 63; 176 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Communication type (Other)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- University of Pennsylvania
- Primary completion
- Jul 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent of Participants With Visit or Procedure With Provider |
45; 64; 63; 176; 200 | — |
| SECONDARY Percent of Participants With Scheduled Visit or Procedure With Provider |
130; 181; 197; 490; 571 | — |
| SECONDARY Percent of Participants With Completed Telemedicine Visit With Provider |
4; 19; 17; 44; 52 | — |
Summary
Randomized, double-blind, of standard of care vs additional communication and factorial design of intervention letter vs. control letter and EHR vs mail delivery mechanism in patients who canceled visits and did not reschedule over a 90 day period starting March 9, 2020.
Eligibility Criteria
Inclusion Criteria
- Patients with a cancellation or failure to show for a procedure or visit from March 9, 2020 through June 7, 2020 (90 days) and who have not rescheduled as of the date of randomization
Exclusion Criteria
- Death
Data sourced from ClinicalTrials.gov (NCT04418947). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.